Patent Issued for 9 Meters Biopharma’s Potential COVID-19 Treatment Date Published: July 29, 2020 Thinking outside the gut, a Raleigh pharmaceutical upstart is landing support for exploring its tissue-tweaking technology as a possible extension…
Durham biotech uses new funding to acquire gene therapy for eye disease Date Published: July 29, 2020 A Hatteras-backed, early-stage life science company has used its new funding to acquire the exclusive rights to gene therapy platform…
Holly Springs’ Avior Bio launches clinical trial of chronic itch therapy Date Published: July 29, 2020 HOLLY SPRINGS — Less than two years after launching, a small Triangle biotech startup is kicking off its first human…
Hatteras backs $3 million seed round for UNC spin-out with stem-cell platform Date Published: July 28, 2020 A Triangle spin-out company looking to develop its stem-cell technology has wrapped up a $3.1 million seed investment led by…
LabCorp gets FDA approval for pooled Covid-19 testing that increases capacity, saves supplies Date Published: July 28, 2020 Seeking to improve turnaround times for Covid-19 testing, Burlington-based LabCorp (NYSE: LH) has received emergency approval from the U.S. Food…
IQVIA Initiative Gives COVID-19 Researchers Free Access to Global Data Date Published: July 28, 2020 Research Triangle Park-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic…
HIV prevention drug backed by RTI International research takes step toward federal regulation Date Published: July 27, 2020 A technology for HIV prevention that’s been studied for years by researchers in the Triangle has taken a big leap…
Trump visit to highlight Triangle firm’s role in producing possible COVID-19 vaccine Date Published: July 27, 2020 RESEARCH TRIANGLE PARK – North Carolina’s global leadership in biomanufacturing has drawn a major spotlight with a White House announcement…
UNC, Baylor researchers report first successful lymphoma treatment using a cell therapy Date Published: July 27, 2020 CHAPEL HILL – CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to…